Bausch & Lomb CFO granted 81,775 RSUs

Bausch & Lomb Corp reported that EVP and CFO Sam Eldessouky acquired 81,775 common shares through a grant of restricted share units (RSUs) at a price of $0.00 per share.

Rhea-AI Filing Summary

Bausch & Lomb Corp reported that EVP and CFO Sam Eldessouky acquired 81,775 common shares through a grant of restricted share units (RSUs) at a price of $0.00 per share. After this award, he directly holds 473,169 common shares.

The RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. They are scheduled to vest in three equal installments on each of the first three anniversaries of the grant date, generally requiring his continued service. Once vested, the RSUs will be settled in common shares of Bausch & Lomb Corporation.

Insider Trade Summary

Grant/Award: 81,775 shares

Grant/Award 1 txn

Insider Eldessouky Sam

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	81,775	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 473,169 shares (Direct)

Footnotes (1)

1. F1. Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch & Lomb (BLCO) disclose about CFO Sam Eldessouky’s latest equity grant?

Bausch & Lomb disclosed that CFO Sam Eldessouky received a grant of 81,775 restricted share units. These RSUs were awarded under the company’s 2022 Omnibus Incentive Plan and will convert into common shares as they vest over a three-year period.

How many Bausch & Lomb (BLCO) shares does the CFO hold after this Form 4 transaction?

After the RSU grant, CFO Sam Eldessouky is reported to beneficially own 473,169 common shares directly. This figure includes the newly awarded restricted share units that will settle in common shares as they vest according to the plan terms.

What are the vesting terms of the 81,775 RSUs reported in BLCO’s Form 4?

The 81,775 restricted share units are scheduled to vest one-third on each of the first three anniversaries of the grant date. Vesting is generally contingent on the executive’s continued service and the conditions specified in the incentive plan and award agreement.

Were any cash purchases or open-market sales involved in this BLCO Form 4 filing?

No cash purchases or open-market sales were reported. The Form 4 shows a grant of restricted share units at a price of $0.00 per share, reflecting an equity-based compensation award rather than a market transaction involving cash consideration.

Under which plan were the new BLCO restricted share units granted to the CFO?

The restricted share units were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. This plan governs equity awards, including RSUs, and sets the vesting conditions and settlement terms into common shares of the company.

How will the newly granted BLCO RSUs be settled when they vest?

When the RSUs vest, they will be settled in common shares of Bausch & Lomb Corporation. The award terms specify that vested restricted share units convert into the company’s no-par-value common shares, increasing the executive’s actual share ownership at each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:04 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eldessouky Sam

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN A6 L4K 4B4

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/25/2026		A		81,775(1)	A	$0	473,169	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

	/s/ Debra E. Levin, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.